Outpace Bio to present new data on OutSmart™ IL-2/15, a CAR T cell-produced designed cytokine with tumor-localized immune cell activity, at the 2023 annual meeting of the American Society of Gene & Cell Therapy (ASGCT)
Outpace Bio, a leader in protein design for cell therapy, announces presentation at the 2023 Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
The Outpace Press Kit is designed to help journalists research Outpace. Please contact our communications team if you need more information or to schedule an interview.